A phase I clinical and pharmacokinetic study of the multi-drug resistance protein-1 (MRP-1) inhibitor sulindac, in combination with epirubicin in patients with advanced cancer. (Q40330401)
Jump to navigation
Jump to search
scientific article published on 27 April 2006
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A phase I clinical and pharmacokinetic study of the multi-drug resistance protein-1 (MRP-1) inhibitor sulindac, in combination with epirubicin in patients with advanced cancer. |
scientific article published on 27 April 2006 |
Statements
A phase I clinical and pharmacokinetic study of the multi-drug resistance protein-1 (MRP-1) inhibitor sulindac, in combination with epirubicin in patients with advanced cancer (English)
O'Leary M
Ballot J
Collins CD
Kinsella P
Mager DE
Larkin A
Kennedy S
Fennelly D
Clynes M
27 April 2006
1 reference